Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Kinetics and Metabolism of Nicotinamide Provided as a Dietary Supplementation [NA]
This clinical trial update describes the pharmacokinetics and metabolism of nicotinamide provided as a dietary supplement, with relevance to…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal) [Phase 2, Phase 3]
This is a protocol for a randomized adaptive platform trial evaluating pathogen-directed anti-inflammatory therapy for severe community-acqu…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients [Phase 2]
A Phase 2 study evaluating Allocetra-OTS for organ failure in adult sepsis patients has completed, examining efficacy, safety, and tolerabil…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D) [Phase 4]
This Phase 4 clinical trial in Denmark is evaluating the optimal duration of antibiotic treatment for adults with community-acquired pneumon…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Validation Study on a Prognostic Prediction Model for Respiratory Tract Infections
Clinical trials.gov entry describing a validation study of a prognostic prediction model for respiratory tract infections. The conditions in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-08-06FDA Approved: TIGECYCLINE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for tigecycline from Apotex Corp, indicating an approved addition or update under the supplemental f…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAP [NA]
Trial evaluating early molecular detection coupled with urinary tests for infectious agents in pediatric community-acquired pneumonia has co…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pneumonia (sCAP) in Elderly Patients"
Clinical trial ESCAPE10 is studying epidemiology, risk factors, and outcomes of severe community-acquired pneumonia in elderly patients and …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP) [Phase 4]
This clinical trial update describes a Phase 4 study evaluating the efficacy and safety of faropenem in Bangladeshi adults with community-ac…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Efficacy and Safety of SR1375 in Adult Patients With CAP [Phase 2]
Phase 2 clinical trial update for SR1375 in adults with community-acquired pneumonia, highlighting the ongoing assessment of efficacy and sa…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia [NA]
A University of Vermont study is evaluating neuromuscular electrical stimulation in patients with COPD exacerbation or community-acquired pn…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia [Phase 3]
Phase 3 study of Trimodulin (BT588) for community-acquired pneumonia including COVID-19 pneumonia was terminated.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Pneumonia Pathogens' Virulence Factors, Patient Inflammatory Markers, and Their Associations With Outcomes
An ongoing clinical trial update explores how virulence factors of pneumonia pathogens and patient inflammatory markers relate to outcomes. …
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia
A prospective hospital registry enrolling patients with suspected or confirmed COVID-19 and community-acquired pneumonia; the study is curre…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia [NA]
A clinical trial is exploring noninvasive support methods for acute respiratory failure in community-acquired pneumonia, with no recruitment…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea [NA]
This clinical trial update evaluates the appropriateness of antibiotic combination therapy for severe community-acquired pneumonia in South …
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France
This clinical trial update reports on the distribution of pneumococcal serotypes among adults hospitalized with pneumococcal community-acqui…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Multimodal Database and Large Language Model for ARDS
A new clinical trial is planned to develop a multimodal database and a large language model to study Acute Respiratory Distress Syndrome and…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia. [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating twice-daily amoxicillin for non-severe community-acquired pneumonia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy [NA]
ClinicalTrials.gov entry describes a study evaluating awake prone positioning for patients with community-acquired pneumonia who require nas…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Effectiveness of the PCV13 in Older Thai Adults
A completed trial from Mahidol University evaluated the effectiveness of the 13-valent pneumococcal conjugate vaccine (PCV13) in older adult…
-
EMA approval · 2025-04-29EMA Authorised: Xenleta (lefamulin acetate) — Nabriva Therapeutics Ireland DAC
The European Medicines Agency authorised Xenleta (lefamulin acetate) for treatment of community-acquired pneumonia, expanding options for ba…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Advanced Diagnostics for Enhanced QUality of Antibiotic Prescription in Respiratory Tract Infections in Emergency Rooms [NA]
A completed clinical trial evaluating advanced diagnostics aimed at improving antibiotic prescribing for community-acquired acute lower resp…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia [NA]
A clinical trial is investigating high-dose inhaled nitric oxide for treating pneumonia, including nosocomial and community-acquired pneumon…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia [Phase 3]
Phase 3 trial comparing omadacycline to moxifloxacin for community-acquired bacterial pneumonia has completed and posted results.